Evaluation of the possibilities of using calculation methods for estimating the glomerular filtration rate depending on the nosological type of socially significant diseases


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. Evaluation of the possibility of using various methods for calculating glomerular filtration rate (GFR) with the determination of the incidence of renal dysfunction depending on the nosological type of socially significant diseases. Material and methods. The subjects of the study were represented by 728 patients suffering from various socially significant diseases, 330 (45.3%) men and 398 (54.7%) women aged 16 to 98 years (mean age 5O.5±l4.2 years). Serum creatinine and cystatin с levels were determined. The glomerular filtration rate (GFR) was calculated using the following formulas: CKD-EPI (2011), MDRD (2000), Cokcroft-Gault (1976) and F.J. Hoek (2003). The entire sample was divided into 9 subgroups depending on the nosological type of the disease: 1 - obesity; 2 - arterial hypertension (Ah); 3 - coronary artery disease (Cad); 4 - diabetes mellitus (Dm); 5 - primary nephropathy (chronic glomerulonephritis and pyelonephritis); 6 - chronic obstructive pulmonary disease (COPD); 7 - cerebrovascular diseases (CVDs); 8 - comorbid diseases, and 9 - general group. a comparative analysis of the frequency of occurrence of renal dysfunction depending on the method of calculating the GFR was performed. The median and interquartile range of GFR were calculated depending on the formula for calculating the GFR in different clinical subgroups. a correlation analysis of the relationship between GFR and blood serum creatinine and cystatin с levels depending on the calculation formula in different clinical subgroups was carried out. Results. a decrease in GFR in the range of 90-60 ml/min was detected in 29.3% according to the CKD-EPI formula, in 36.6% - according MDRD formula, in 24.3% - according Cokcroft-Gault, and in 71.2% according the method of F.J. Hoek. The largest number of patients with reduced GFR less than 60 ml/min was noted according to the method of F.J. Hoek (48.2%) and MDRD formula (25.i%). Relatively lower GFR value according to F.J. Hoek was recorded in a subgroup of patients with diabetes and primary renal pathology (glomerulonephritis/pyelonephritis). In patients with obesity, ah, COPD, CVDs and in the total sample, there was a significant decrease in GFR according to the method of F.J. Hoek compared to CKD-EPI, MDRD and Cokcroft-Gault formulas. GFR calculated on the basis of serum creatinine level according CKD-EPI formula gave a statistically highly significant relationship in the subgroup of patients with COPD (R=-0.756; P=O.OOl) and primary nephropathies (R=-0.781; P=O.OOl). a similar significant strong correlation according to the MDRD equation was observed in the subgroup of patients with COPD (R=-O.852; P=O.OOl). Compared to other subgroups, the correlation coefficient between serum creatinine level and estimated GFR using the Cokcroft-Gault formula was not as strong among patients with cad (R=-O.484; P=O.OO5). GFR calculated using the F.J. Hoek method in all the subgroups gave a significant correlation. The correlation of GFR calculated on the basis of serum cystatin с level was stronger in the subgroup of patients with COPD (R=-O.935; P=O.OO1). Conclusion. The prevalence of a mild decrease in GFR according to the F.J. Hoek method in patients with various socially significant diseases was 71.2 and 36.6% according to the MDRD formula. Moderate reduction in renal function in the examined individuals according F.J. Hoek method was revealed in 48.2%, according to the MDRD equation - in 25.1%. The frequency of occurrence of renal dysfunction according to the CKD-EPI and Cokcroft-Gault formulas was equivalent: 29.3; 21.2% AND 24.3; 20.1%, RESPECTIVELY.

Full Text

Restricted Access

About the authors

I. T Murkamilov

Kyrgyz State Medical Academy n.a. I.K. Akhunbaev; Kyrgyz-Russian Slavic University n.a. the First President of the Russian Federation B.N. Yeltsin

Bishkek, Kyrgyzstan

I. S Sabirov

Kyrgyz-Russian Slavic University n.a. the First President of the Russian Federation B.N. Yeltsin

Bishkek, Kyrgyzstan

V. V Fomin

FSBEI he "I.M. Sechenov First Moscow State Medical University''

Moscow, Russia

Zh. A Murkamilova

Center for Family Medicine № 7

Bishkek, Kyrgyzstan

References

  1. Major R.W., Cheng M.R., Grant R.A. et al. Cardiovascular disease risk factors in chronic kidney disease: A systematic review and meta-analysis. PloS one. 2018; 13: 3.C.e0192895. Doi: https://doi.org/10.1371/journal.pone.0192895.
  2. Stel V.S., BrUck K, Fraser S., et al. International differences in chronic kidney disease prevalence: a key public health and epidemiologic research issue. Nephrol. Dial. Transplantat. 2017; 32(2): ii129-ii135. Doi: https://doi.org/10.1093/ndt/gfw420.
  3. Dorans K.S., Mills K.T., Liu Y., He J. Trends in Prevalence and Control of Hypertension According to the 2017. American College of Cardiology. American Heart Association (ACC/AHA) Guideline. J. Am. Heart. Assoc. 2018; 7: 1-11. e008888. Doi: https://doi.org/10.1161/JAHA.118.008888.
  4. Бойцов С.А., Самородская И.В., Никулина Н.Н. и др. Сравнительный анализ смертности населения от острых форм ишемической болезни сердца за пятнадцатилетний период в РФ и США и факторов, влияющих на ее формирование. Тер. архив. 2017; 9(89): 53-9. doi: 10.17116/terarkh201789953-59.
  5. Дедов И.И., Шестакова М.В., Викулова О.К. Эпидемиология сахарного диабета в Российской Федерации: клинико-статистический анализ по данным Федерального регистра сахарного диабета. Сахарный диабет. 2017; 1(20): 13-41. doi: 10.14341/DM8664.
  6. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am. J. Kidney Dis. 2002; 39(1): 1-266.
  7. KDIGO 2012 Clinical Pracice Guidelines for the Evaluaion and Management of Chronic Kidney Disease. Kidney Int. 2013; 3(1): 1-163.
  8. Hoek F.J., Kemperman F.A., Krediet R.T. A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular fi ltration rate. Nephrol. Dial. Transplant. 2003; 18(10): 2024-2031. doi: 10.1093/ndt/gfg349.
  9. Bevc S., Hojs R., Ekart R., et al. Simple cystatin C formula for estimation of glomerular filtration rate in overweight patients with diabetes mellitus type 2 and chronic kidney disease. Exp. Diabet. Res. 2012; 2012: 8. doi: 10.1155/2012/179849.
  10. Hilderink J.M., van der Linden N., Kimenai D.M., et al. Twenty-four-Hour Biological Variation of Creatinine, Cystatin C, and Estimated Glomerular Filtration Rate in People With or Without Chronic Kidney Disease. Clin. Chem. 2017; 63(10): 1655-1656. doi: 10.1373/clinchem.2017.275107.
  11. Батюшин М.М. Методические основы оценки скорости клубочковой фильтрации в урологической практике. Вест. урологии. 2017; 1(5): 42-51. doi: 10.21886/2306-6424-2017-5-1-42-51. [Batiushin M.M. Methodical bases of estimation glomerular filtration rate in urological practice. Urol. herald.2017; 1(5): 42-51. doi: 10.21886/2306-6424-2017-5-1-42-51.
  12. Zhu Z., Zhong C., Xu T., et al. Prognostic significance of serum cystatin C in acute ischemic stroke patients according to lipid component levels. Atheroscler. 274: 146-151. doi: 10.1016/j.atherosclerosis.2018.05.015. (In Russ.)].
  13. Муркамилов И.Т., Сабиров И.С., Фомин В.В. и др. Оценка нефроцере-брального риска с использованием цистатина С у больных хронической болезнью почек. Журн. неврологии и психиатрии им. С.С. Корсакова. 2018; 118(9): 10-16. Doi: https://doi.org/10.17116/jnevro201811809110.
  14. Peralta C.A., Katz R., Sarnak M.J., et al. Cystatin C identifies chronic kidney disease patients at higher risk for complications. J. Am. Soc.Nephrol. 2011; 22: 147-155.
  15. Snyder J.J., Foley R.N., Collins A.J. Prevalence of CKD in the United States: a sensitivity analysis using the National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am. J. Kidney Dis. 2008; 53(2): 218-228. doi: 10.1053/j.ajkd.2008.07.034.
  16. Cockcroft D.W., Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron.1976; 16(1): 31-41. doi: 10.1159/000180580.
  17. Levey A.S., Bosch J.P, Lewis J.B., et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann. Intern. Med. 1999; 130(6): 461-470. doi: 10.7326/0003-4819-130-6-199903160-00002. PMID: 10075613.
  18. Levey A.S., Stevens L.A., Schmid C.H., et al. A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 2009; 150: 604-612.
  19. Дедов И.И., Мельниченко Г.А. Ожирение. М., 2006. С. 19-21. [Dedov I.I., Melnichenko G.A. Obesity. M., 2006. Р. 19-21. (In Russ.)].
  20. Орлов А.И. Прикладная статистика. М., 2006. 671 с. [Orlov A.I. Applied statistics (Prikladnaya statistika). M., 2006. 671 р. (In Russ.)].
  21. Смирнов А.В., Добронравов В.А., Каюков И.Г. и др. Хроническая болезнь почек: основные принципы скрининга, диагностики, профилактики и подходы к лечению. Национальные рекомендации. Нефрология. 2012; 1(16): 89-115.
  22. Муркамилов И.Т., Айтбаев К.А., Фомин В.В. и др. Влияние массы тела и артериальной гипертензии на структурную перестройку сердца при хроническом гломерулонефрите. Здоровье и образование в XXI веке. 2018; 4(20): 9-17. Doi: http://dx.doi.org/10.26787/nydha-2226-7425-2018-204-9-17.
  23. Переверзева Е.В., Гулько А.Ю., Вабищевич Ю.Э. и др. Сопоставление показателей скорости клубочковой фильтрации, определенных разными методами, у мужчин призывного возраста с артериальной гипертензией. Вест. Смоленской государственной медицинской академии. 2016; 1(15): 23-8.
  24. Смирнов А.В., Шилов Е.М., Добронравов В.А. и др. Национальные рекомендации. Хроническая болезнь почек: основные принципы скрининга, диагностики, профилактики и подходы к лечению. Клин. нефрология. 2012; 4: 4-26.
  25. Matsushita K., Mahmodi B.K., Woodward M., et al. Comparison of the risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA. 2012; 307: 1941-1951.
  26. Кобалава Ж.Д., Виллевальде С.В., Ефремовцева М.А. Хроническая болезнь почек: определение, классификация, принципы диагностики и лечения. Рос. кардиол. журн. 2013; 4(102): 95-103. doi: https://doi.org/10.15829/1560-4071-2013-4-95-103.
  27. Ощепкова Е.В.,Долгушева Ю.А.,Жернакова Ю.В. и др. Распространенность нарушения функции почек при артериальной гипертонии (по данным эпидемиологического исследования ЭССЕ-РФ). Системные гипертензии. 2015; 3(12): 19-24.
  28. Кулаков В.В., Виллевальде С.В., Кобалава Ж.Д. Распространенность маркеров хронической болезни почек у пациентов с артериальной гипертонией и сахарным диабетом в реальной практике. Трудный пациент. 2017; 3(15): 49-53.
  29. Hougardy J.M., Delanaye P., Le Moine A., Nortier J. Estimation of the glomerular filtration rate in 2014 by tests and equations: strengths and weaknesses. Rev. Med. Brux. 2014; 4(35): 250-257. PMID: 25675627.
  30. Кардиология: национальное руководство. Под ред. Е.В. Шляхто. М., 2015. 800 с. [Cardiology: national leadership. Ed by E.V. Shlyakhto. M., 2015. 800p. (In Russ.)].
  31. Chang A.R., Appel L.J. Target Blood Pressure for Cardiovascular Disease Prevention in Patients with CKD. Clin. J. Am. Soc. Nephrol. 2018; 13(10): 1572-1574. Doi: https://doi.org/10.2215/CJN.02130218.
  32. Попова И.Р., Торчинский Н.В., Драпкина О.М., Ивашкин В.Т. Оценка функционального состояния почек у пациентов с избыточной массой тела и ожирением. Клиницист. 2012; 2: 36-40.
  33. Сабодаш А.Б., Команденко М.С., Шостка Г.Д. Сравнение различных методик определения остаточной функции почек. Нефрология. 2005; 9(2): 61-6. Doi: https://doi.org/10.24884/1561-6274-2005-9-2-61-66.
  34. McFadden E.C., Hirst J.A., Verbakel J.Y., et al. Systematic review and metaanalysis comparing the bias and accuracy of the Modification of Diet in Renal Disease and Chronic Kidney Disease Epidemiology Collaboration equations in community-based populations. Clin. Chem. 2018; 64: 3: 475-485. doi: 10.1373/clinchem.2017.276683.
  35. Bhuvanakrishna T., Blake G. M., Hilton R., et al. Comparison of estimated GFR and measured GFR in prospective living kidney donors. Int. Urol. Nephrol. 2015; 47: 1: 201-208. doi: 10.1007/s11255-014-0859-y.
  36. Wróbel P., Sulowicz W. Comparison of the prevalence of chronic kidney disease in patients of the Emergency Department of the Regional Hospital in Kielce based on GFR estimation according abbreviated MDRD formula or CKD-EPI equation. Przeglad lekarski. 2016; 7(73): 465-471.
  37. Bjork J., Back S.E., Ebert N., et al. GFR estimation based on standardized creatinine and cystatin C: a European multicenter analysis in older adults. Clin. Chem. Lab. Med. (CCLM). 2018; 56: 3: 422-435. Doi: https://doi.org/10.1515/cclm-2017-0563.
  38. Sans L., Radosevic A., Quintian C., et al. Cystatin C estimated glomerular filtration rate to assess renal function in early stages of autosomal dominant polycystic kidney disease. PloS One. 2017; 12: 3. e0174583. Doi: https://doi.org/10.1371/journal.pone.0174583.
  39. Dangle P.P., Ayyash O., Kang A., et al. Cystatin C-calculated glomerularfiltration rate - a marker of early renal dysfunction in patients with neuropathic bladder. Urol. 2017; 100: 213-217. Doi: https://doi.org/10.1016/j.urology.2016.08.011.
  40. Муркамилов И.Т., Айтбаев К.А., Фомин В.В. и др. Содержание цистатина С плазмы крови и его взаимосвязь с аугментационным индексом и центральным артериальным давлением у пациентов терапевтического профиля. Клин. нефрология. 2018; 3: 31-40. doi: 10.18565/nephrology.20183.31-40.
  41. Ebert N., Schaeffner E. New biomarkers for estimating glomerular filtration rate. J. Lab. Prec. Med. 2018; 375: 1-11. doi: 10.21037/jlpm.2018.08.07.
  42. He L., Li J., Zhan J., et al. The value of serum cystatin C in early evaluation of renal insufficiency in patients undergoing chemotherapy: a systematic review and meta-analysis. Cancer Chemother. Pharmacol. 2019; 1-11. Doi: https://doi.org/10.1007/s00280-018-3762-x.
  43. Mirza S., Clay R.D., Koslow M.A., Scanlon P.D. COPD Guidelines: A Review of the 2018 GOLD Report. Mayo Clin. Proc. Elsev. 2018; 93: 10: 1488-502. Doi: https://doi.org/10.1016/j.mayocp.2018.05.026.
  44. Долгополова Д.А. Предикторы развития хронической болезни почек у больных хронической обструктивной болезнью легких. Клиницист. 2016; 10: 3: 51-57. Doi: 10.17 650/1818-8338-2016-10-3-51-57.
  45. Leung J., Chen V., Hollander Z., et al. High Cystatin-C Levels May Predict Imminent COPD Exacerbations//A103. COPD: Disease progression and prognosis. Am. Thor. Soc. 2017; A2729-A2729.
  46. Zhang M., Li Y., Yang X., et al. Serum cystatin C as an inflammatory marker in exacerbated and convalescent COPD patients. Inflammation. 2016; 39: 2: 625-631. Doi: https://doi.org/10.1007/s10753-015-0287-x.
  47. Яркова Н.А., Боровков Н.Н., Занозина О.В., Носов В.П. Цистатин С в диагностике хронической болезни почек у больных сахарным диабетом 2-го типа. Совр. технологии в медицине. 2013; 5(4): 89-93.
  48. Coca S.G., Yalavarthy R., Concato J., Parikh C. R. Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review. Kidney Int. 2008; 73: 9: 1008-1016. Doi: https://doi.org/10.1038/sj.ki.5002729.
  49. Kilbride H.S., Stevens P.E., Eaglestone G., et al. Accuracy of the MDRD (Modification of Diet in Renal Disease) study and CKD-EPI (CKD Epidemiology Collaboration) equations for estimation of GFR in the elderly. Am. J. Kidney Dis. 2013; 1(61): 57-66. doi: 10.1053/j.ajkd.2012.06.016.
  50. Levey A.S., Bosch J.P., Lewis J.B. A more accurate method to estimate glomerular filtration rate from serum creatinine; a new prediction equation. Ann. Intern. Med.1999; 130(8): 461-470.
  51. Levey A.S., Greene T., Kusek J.W., Beck G.J. A simplified equation to predict glomerular filtration rate from serum creatinine. J. Am. Soc. Nephrol. 2000; 11: A0828.
  52. Ibrahim S., Rashid L., Darai M. Modification of diet in renal disease equation underestimates glomerular filtration rate in egyptian kidney donors. Exp. Clin. Transplant. 2008; 6(2): 144-148.
  53. Ma Y.C., Zuo L., Chen J.H., et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J. Am. Soc. Nephrol. 2006; 17(10): 2937-2944.
  54. Каретникова В.Н., Осокина А.В., Евсеева М.В. и др. Формулы оценки функции почек при прогнозировании отдаленных сердечно-сосудистых исходов у больных инфарктом миокарда в сочетании с сахарным диабетом. Тер. архив. 2016: 4(88): 35-40. doi: 10.17116/terarkh201688435-40.
  55. Clase C.M., Garg A.X., Kiberd B.A. Prevalence of low glomerular filtration rate in nondiabetic Americans: Third National Health and Nutrition Examination Survey (NHANES III). J. Am. Soc. Nephrol. 2002; 5(13): 1338-1349. Doi: https://doi.org/10.1097/01.ASN.0000013291.78621.26.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies